Anzeige
Erschienen in:
26.09.2016 | Case Report
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam
Erschienen in: Infection | Ausgabe 1/2017
Einloggen, um Zugang zu erhaltenAbstract
Introduction
Ceftolozane/tazobactam is a novel antibiotic approved for the treatment of complicated intra-abdominal and complicated urinary tract infections.
Case description
We describe the use of off-label ceftolozane/tazobactam in the management of a multidrug-resistant Pseudomonas aeruginosa bacteremia that was already being treated with colistin and amikacin, the only active antibiotics according to the antibiogram.